Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Second Phone Call 814 Days After The Initial Visit

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Second Phone Call 814 Days After The Initial Visit1
  • Onsite Recruitment Information And Consent Following A Random Sampling Recruitment Schedule1
  • First Phone Call 13 Days After The Initial Visit1

Active Sponsors

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1
  • Simon Berthelot1

Top Investigators

Related Conditions

  • Costs1
  • Covid191
  • Quality Of Care1
  • Epilepsy1
  • Ambulatory Care1

Activity Timeline